Life Sciences Institute

Life Sciences Institute (LSII) is a core healthcare subsidiary of the Mitsubishi Chemical Group, focused on advancing regenerative medicine and innovative healthcare solutions. The company's primary focus is the development of Muse cells (Multilineage-differentiating Stress Enduring cells), a unique type of endogenous non-tumorigenic pluripotent stem cell discovered in human tissues. LSII is currently advancing a clinical pipeline targeting high-unmet-need conditions such as acute myocardial infarction, ischemic stroke, and amyotrophic lateral sclerosis. Beyond regenerative medicine, the company provides a broad range of healthcare services, including clinical testing and diagnostic support, leveraging its integration within one of Japan's largest chemical conglomerates.